Program selects Eyenuk’s EyeArt AI system to make vision-saving screening more accessible in remote Ontario communities LOS ANGELES and TORONTO, August 16, 2022 – Vision Loss Rehabilitation Canada (VLRC), Canada’s …
June 14, 2022 – In a recent article published by the Portland Press-Herald, the EyeArt® AI System was featured as a cutting-edge technology implemented through support from MaineHealth Innovation. This …
LOS ANGELES, June 8, 2022 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI …
LOS ANGELES, June 1, 2022 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI …
May 17, 2022 – Meritus Health, the largest provider of healthcare in western Maryland, recently adopted the EyeArt® artificial intelligence (AI) system for autonomous diabetic retinopathy testing in its primary …
Meritus Health Adopts the EyeArt® AI System for Autonomous Diabetic Eye Testing Read More »
March 21, 2022 – University of Utah Health, provider of care to patients in Utah and the broader Mountain West region and home to the only academic medical center in …
University of Utah Implements the EyeArt® AI System for Autonomous Diabetic Eye Testing Read More »
Eyenuk was recently higlighted in a Reuters Legal feature discussing the historic decision by the United States Centers for Medicare and Medicaid Services to reimburse providers for the use of …
A new diabetic retinopathy screening benefit enabled by the EyeArt® AI system is made available by Discovery Health, a global leader in Healthcare and Financial Services LOS ANGELES, December 7, …
Eyenuk Launches EyeArt AI System in South Africa in Collaboration with Discovery Health Read More »
The published results demonstrate exceptional EyeArt accuracy in a pre-registered, prospective, multicenter clinical trial Los Angeles, November 15, 2021 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and …
The CMS Final Rule establishes a national payment for CPT code 92229 that describes Eyenuk’s FDA-cleared EyeArt® AI system and confirms that AI can be used to close care gaps …
August 24, 2021 – Eyenuk is proud to announce the expansion of our customer base in Germany for automated diabetic retinopathy (DR) detection by the EyeArt® artificial intelligence (AI) system. …
Top German Diabetes Centers Adopt Eyenuk AI Technology Read More »
Eyenuk’s clinical partner in Virginia has been awarded a government telemedicine grant to improve diabetic eye screening in rural Virginia. Clinical partners must be located in rural Virginia to be …
April 7, 2021 – The Institute of Ophthalmology and Visual Science (IOVS) at Rutgers New Jersey Medical School, the oldest medical school in New Jersey and a leading U.S. healthcare …
March 30, 2021 – The March/April 2021 edition of Retina Specialist magazine includes a feature article emphasizing the readiness of artificial intelligence (AI) for use in screening for diabetic retinopathy …
EyeArt is the First FDA Cleared AI Technology for Autonomous Detection of Both More than mild and Vision-Threatening Diabetic Retinopathy Los Angeles, CA, August 5, 2020 — Eyenuk, Inc., a …
ENGLAND, April 15, 2020 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced that it …
LOS ANGELES, April 2, 2020 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today …
Eyenuk Reports Strong First Quarter 2020 Commercial Results Read More »
KOLOA, Hawaii, USA – Jan 22, 2020 An article on Helio.com titled, “Eyenuk’s AI screening program detects referable diabetic retinopathy“, highlighted the Retina 2020 conference presentation by Dr. Michael S. …
In cooperation with the World Diabetes Foundation and the Ministry of Health of Armenia, the Armenian EyeCare Project is implementing a nationwide screening program using state-of-the-art AI technology. 350 patients …
Dr. Srinivas Sadda of Doheny Eye Institute presented new research at AAO 2019 that shows that EyeArt®, an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy 95.5 percent …
